Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and perception of surgery-specific goals of care discussions in the preoperative setting: A learning pilot.
Letica-Kriegel AS, Rosen R, McNeil N, Thompson E, James M, Broach V, Roche KL, Riportella M, Ng S, Bernal C, Vaynrub M, Downey R, Voigt L, Epstein AS, Nelson J, Goldfrank D, Nash GM. Letica-Kriegel AS, et al. Among authors: roche kl. J Surg Oncol. 2024 Mar 28. doi: 10.1002/jso.27632. Online ahead of print. J Surg Oncol. 2024. PMID: 38549286
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Byrne M, Sia TY, Fong C, Khurram A, Waters M, Kemel YM, Zhou Q, Ranganathan M, Roche KL, Chi DS, Saban S, Wu M, Varice N, Hamilton JG, Carrot-Zhang J, Abu-Rustum NR, Iasonos A, Ellenson LH, Mandelker D, Weigelt B, Brown CL, Aghajanian C, Stadler Z, Liu YL. Byrne M, et al. Among authors: roche kl. Gynecol Oncol. 2024 Mar 14:S0090-8258(24)00144-6. doi: 10.1016/j.ygyno.2024.03.005. Online ahead of print. Gynecol Oncol. 2024. PMID: 38493020
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Kahn RM, Selenica P, Boerner T, Roche KL, Xiao Y, Sia TY, Maio A, Kemel Y, Sheehan M, Salo-Mullen E, Breen KE, Zhou Q, Iasonos A, Grisham RN, O'Cearbhaill RE, Chi DS, Berger MF, Kundra R, Schultz N, Ellenson LH, Stadler ZK, Offit K, Mandelker D, Aghajanian C, Zamarin D, Sabbatini P, Weigelt B, Liu YL. Kahn RM, et al. Among authors: roche kl. Gynecol Oncol. 2024 Jan;180:35-43. doi: 10.1016/j.ygyno.2023.11.019. Epub 2023 Dec 1. Gynecol Oncol. 2024. PMID: 38041901
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications.
Feinberg J, Zivanovic O, Hannon M, McCready T, Desai P, Kim SH, Aviki EM, Mueller JJ, Jewell EL, Roche KL, Gardner GJ, Chi DS, Sonoda Y, Brown CL, Abu-Rustum NR, Cracchiolo JR, Leitao MM Jr, Broach V. Feinberg J, et al. Among authors: roche kl. Gynecol Oncol. 2023 Aug;175:163-168. doi: 10.1016/j.ygyno.2023.06.011. Epub 2023 Jun 28. Gynecol Oncol. 2023. PMID: 37390597
Germline drivers of gynecologic carcinosarcomas.
Sia TY, Gordhandas SB, Birsoy O, Kemel Y, Maio A, Salo-Mullen E, Sheehan M, Hensley ML, Rubinstein M, Makker V, Grisham RN, O'Cearbhaill RE, Roche KL, Mueller JJ, Leitao MM Jr, Sonoda Y, Chi DS, Abu-Rustum NR, Berger MF, Ellenson LH, Latham A, Stadler Z, Offit K, Aghajanian C, Weigelt B, Mandelker D, Liu YL. Sia TY, et al. Among authors: roche kl. Gynecol Oncol. 2023 Jul;174:34-41. doi: 10.1016/j.ygyno.2023.04.024. Epub 2023 May 5. Gynecol Oncol. 2023. PMID: 37149903
33 results